Assessment of NTproBNP Concentration in Asymptomatic Cats with Cardiomyopathy
ACVIM 2008
P.R. Fox1; M.A. Oyama2; K. MacDonald3; C.A. Reynolds2
1Animal Medical Center, New York, NY, USA; 2University of Pennsylvania, Philadelphia, PA, USA; 3Animal Care Center, Rohnert Park, CA, USA

Myocytes express and release natriuretic peptides in response to pressure or volume overload. Diagnosis of cardiomyopathy in asymptomatic cats is challenging and generally requires echocardiographic examination. We aimed to determine whether NTproBNP blood concentrations were elevated in cats with asymptomatic myocardial disease (HCM, DCM, UCM).

Asymptomatic cats with a heart murmur or gallop rhythm were each evaluated by a board certified cardiologist using medical history, physical examination, thoracic radiography, and echocardiography. Healthy cats similarly evaluated and free of cardiovascular disease comprised a control group. A central laboratory blinded to diagnosis performed serum NTproBNP assays. Control vs cardiomyopathy NTproBNP concentrations were compared by Mann Whitney test. Spearman correlation assessed NTproBNP concentrations vs echocardiographic measurements in cardiomyopathy cats. ROC analysis was used to evaluate NTproBNP outcomes.

Median NTproBNP differed between control (n=14) vs cardiomyopathy (n=23) groups (P<0.0001). Median NTproBNP [interquartile range] was 24 pmol/L [24-45.5pmol/L] for control cats and 283pmol/L [154-603pmol/L] for cardiomyopathy cats. Correlations (BNP vs echo) were LVWd (P=0.18), LVd (P=0.497), LVs (P=0.424), %FS (P=0.978), IVSd (P=0.434), LA/Ao (P=0.199) and vertebral heart score (P=0.9).

NTproBNP >70 pmol/L possessed 87.5% sensitivity, 100% specificity, 100% positive predictive value, and 87.5% negative predictive value for asymptomatic cardiomyopathy vs controls (fitted ROC area under curve, 0.982 [SE=0.0193]). Therefore, NTproBNP determination may aid clinical evaluation of asymptomatic cats with myocardial disease.

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

Philip Fox, DVM, DACVIM/DECVIM-CA (Cardiology), DACVECC
Animal Medical Center
New York, NY

MAIN : SA Cardiology : NTproBNP Concentration
Powered By VIN